Technology can help reduce error rates in IV compounding.
PBMs are evolving, but what will they be evolving into and will they be more transparent?
In Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.
In Clinical Challenge, we give you one case and two different expert opinions. You decide the best approach.
Edaravone has been approved for patients with amyotropic lateral sclerosis.
Antimicrobial susceptibility testing (AST) for newer antibiotics is falling behind because there is a lag time between FDA approval and inclusion in commercial AST devices.
Pharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
A new era of treatment has arrived-here’s what you need to know.
Pharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
Pharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
It's time for pharmacies to move into the future: Industry 4.0.
Queueing theory can help pharmacy managers control lines, wait times, and staffing issues.
Pharmacists can help women who breastfeed by identifying the safest drugs and dosage schedules to minimize exposure.
The FDA recently approved cannabidiol oral solution to treat seizures.
Being recognized as a BCPP brings professional recognition and credibility as an expert in psychopharmacology and behavioral health matters.
In this month's peer-reviewed article, learn more about the illness affecting millions.
In this month's peer-reviewed article, learn more about the illness affecting millions.
In this month's peer-reviewed article, learn more about the illness affecting millions.
AACP offers a rebuttal to a Drug Topics opinion article.
With 2016 well underway, pharmacies of all sizes should review recent regulatory updates to ensure compliance with rules already in effect, and preparation for those to be implemented soon. Three, in particular, warrant a close look.
Understanding headaches and their various treatment options can help pharmacists counsel patients at the counter.
Rolapitant is a novel NK1 receptor antagonist that maintains >90% receptor binding up to five days after a single 180-mg dose.
New developments in cancer treatment require medication experts-here's how you can become that expert.
Analysts have forecasted the market for NASH drugs could reach $20 billion by 2025.